The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclusion from stateRegister of medicinal products for the medical use of the medicinal product (registration certificate P N015367 / 01 dated 02.04.2011 issued by Eli Lilly East SA, Switzerland):
ReoPro (the trade name of the medicinal product)
Abciximab (international non-proprietary, or grouping, or chemical name medicinal product)
Solution for intravenous administration, 2 mg / ml (dosage form, dosage)
Silag AG, Switzerland
Cilag AG, Hochstrasse 201, 8205 Schaffhausen, Switzerland (name and address of the location of the manufacturer of the medicinal product) on the basis of filing by the authorized legal entity of the MP of JSC "Eli Lilly Vostok SA", Russia, a request for the cancellation of the state registration of the medicinal product.